☰
  • Home
  • Blog
  • Policy Papers
  • Analysis
  • Report Cards
  • Summits
  • You’re Invited
Logo
  • Blog
  • Policy Papers
  • Report Cards
  • Analysis
  • Summits

Biomarker Testing: Allowing Individualized Treatment for Cancer Patients

March 24, 2022

Biomarkers are predictive markers in genetic material that can indicate which medications might work for a given patient. For cancer patients, biomarker testing is an important first step toward tailored treatment.

Read Paper

Tags: Biomarker Testing, Oncology

Categorized in: Policy Briefs, Policy Papers

2020 K Street NW, Suite 505 Washington, DC 20006 (202) 964-2624

About Us Archive

© 2025 Copyright Institute for Patient Access

Website Management provided by Genacom